JP2024545420A5 - - Google Patents
Info
- Publication number
- JP2024545420A5 JP2024545420A5 JP2024532444A JP2024532444A JP2024545420A5 JP 2024545420 A5 JP2024545420 A5 JP 2024545420A5 JP 2024532444 A JP2024532444 A JP 2024532444A JP 2024532444 A JP2024532444 A JP 2024532444A JP 2024545420 A5 JP2024545420 A5 JP 2024545420A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163284497P | 2021-11-30 | 2021-11-30 | |
| US63/284,497 | 2021-11-30 | ||
| US202163292120P | 2021-12-21 | 2021-12-21 | |
| US63/292,120 | 2021-12-21 | ||
| US202163293519P | 2021-12-23 | 2021-12-23 | |
| US63/293,519 | 2021-12-23 | ||
| US202263332530P | 2022-04-19 | 2022-04-19 | |
| US63/332,530 | 2022-04-19 | ||
| US202263367678P | 2022-07-05 | 2022-07-05 | |
| US63/367,678 | 2022-07-05 | ||
| PCT/US2022/080700 WO2023102448A2 (en) | 2021-11-30 | 2022-11-30 | Coronavirus vaccine formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024545420A JP2024545420A (ja) | 2024-12-06 |
| JP2024545420A5 true JP2024545420A5 (https=) | 2025-11-13 |
| JPWO2023102448A5 JPWO2023102448A5 (https=) | 2025-11-13 |
Family
ID=86613115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532444A Pending JP2024545420A (ja) | 2021-11-30 | 2022-11-30 | コロナウイルスワクチン製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250025549A1 (https=) |
| EP (1) | EP4440613A4 (https=) |
| JP (1) | JP2024545420A (https=) |
| KR (1) | KR20240125935A (https=) |
| AU (1) | AU2022399829A1 (https=) |
| CA (1) | CA3241118A1 (https=) |
| IL (1) | IL313254A (https=) |
| MX (1) | MX2024006589A (https=) |
| TW (1) | TW202332685A (https=) |
| WO (1) | WO2023102448A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| WO2024089638A1 (en) * | 2022-10-28 | 2024-05-02 | Glaxosmithkline Biologicals Sa | Nucleic acid based vaccine |
| US20250144200A1 (en) | 2023-11-06 | 2025-05-08 | Novavax, Inc. | Intranasal immunogenic compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3165371A1 (en) * | 2020-01-27 | 2021-08-05 | Gale Smith | Coronavirus vaccine formulations |
| JP2023511633A (ja) * | 2020-01-28 | 2023-03-20 | モデルナティエックス インコーポレイテッド | コロナウイルスｒｎａワクチン |
| TW202204380A (zh) * | 2020-01-31 | 2022-02-01 | 美商詹森藥物公司 | 用於預防及治療冠狀病毒感染之組合物及方法－sars-cov-2疫苗 |
| KR20240123835A (ko) * | 2021-12-23 | 2024-08-14 | 노바백스, 인코포레이티드 | 항-SARS-CoV-2 스파이크(S) 항체 및 COVID-19 치료에서의 그의 용도 |
| CN119836572A (zh) * | 2022-07-26 | 2025-04-15 | 诺瓦瓦克斯股份有限公司 | 用于评价疫苗免疫原性的ace2抑制测定 |
| JP2025524959A (ja) * | 2022-07-26 | 2025-08-01 | ノババックス，インコーポレイテッド | ワクチン免疫原性を評価するためのシュードウイルスベースの中和アッセイ |
-
2022
- 2022-11-30 KR KR1020247021797A patent/KR20240125935A/ko active Pending
- 2022-11-30 IL IL313254A patent/IL313254A/en unknown
- 2022-11-30 WO PCT/US2022/080700 patent/WO2023102448A2/en not_active Ceased
- 2022-11-30 US US18/715,010 patent/US20250025549A1/en active Pending
- 2022-11-30 AU AU2022399829A patent/AU2022399829A1/en active Pending
- 2022-11-30 CA CA3241118A patent/CA3241118A1/en active Pending
- 2022-11-30 TW TW111145944A patent/TW202332685A/zh unknown
- 2022-11-30 JP JP2024532444A patent/JP2024545420A/ja active Pending
- 2022-11-30 MX MX2024006589A patent/MX2024006589A/es unknown
- 2022-11-30 EP EP22902377.5A patent/EP4440613A4/en active Pending